This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making health decisions based on this content.
By SterlingMedicalCenter.org Editorial Team | Last verified: August 2026
In This Article
- What Chronic Kidney Disease Stages Are
- How Kidney Function Declines Across CKD Stages
- What Research Shows About CKD Progression and Outcomes
- Diagnosis Across Chronic Kidney Disease Stages
- Who Should Be Evaluated and When Treatment Adjusts by Stage
- Lifestyle Measures and Dietary Recommendations by CKD Stage
- Safety Considerations and Complications Across CKD Stages
- Key Takeaway: Chronic Kidney Disease Stages
What Chronic Kidney Disease Stages Are
Chronic kidney disease (CKD) is a long-term condition in which the kidneys gradually lose their ability to filter waste and excess fluid from the blood. By definition, CKD requires abnormal kidney function or structure to be present for at least three months. Healthcare providers use a five-stage classification system to describe how much kidney function remains.
The stages are based primarily on the estimated glomerular filtration rate (eGFR)—a measurement of how many milliliters of waste the kidneys can filter from blood each minute per 1.73 square meters of body surface area (mL/min/1.73m²). This number directly reflects kidney function:
- Stage 1 CKD: eGFR ≥ 90 mL/min/1.73m² — Normal or high kidney function, but evidence of kidney disease (usually protein in urine)
- Stage 2 CKD: eGFR 60–89 mL/min/1.73m² — Mildly decreased kidney function with evidence of kidney disease
- Stage 3a CKD: eGFR 45–59 mL/min/1.73m² — Mildly to moderately decreased kidney function
- Stage 3b CKD: eGFR 30–44 mL/min/1.73m² — Moderately to severely decreased kidney function
- Stage 4 CKD: eGFR 15–29 mL/min/1.73m² — Severely decreased kidney function
- Stage 5 CKD: eGFR < 15 mL/min/1.73m² — Kidney failure; requires dialysis or transplant for survival
The presence of protein in the urine (proteinuria or albuminuria) is also documented alongside eGFR, as it indicates kidney damage independent of filtration rate and helps predict progression and complications.
How Kidney Function Declines Across CKD Stages
Understanding what happens at each stage helps explain why early detection and management are critical:
Stages 1–2: Early Disease, Often Asymptomatic
In early stages, most people have no symptoms. The kidneys are still compensating well. Disease is detected through routine screening (blood creatinine levels or urine protein), often in people with risk factors like diabetes, high blood pressure, or family history of kidney disease. At this point, aggressive management of blood pressure and blood sugar can significantly slow progression.
Stages 3a–3b: Moderate Kidney Disease
As kidney function declines to 30–59% of normal, the kidneys begin to struggle with waste and fluid removal. Mild symptoms may emerge, including fatigue and subtle changes in urination patterns. Complications begin to develop: blood pressure often rises, anemia may start (from reduced erythropoietin production), and bone disease can begin. Medication adjustments and dietary changes become increasingly important.
Stages 4–5: Severe and End-Stage Disease
When kidney function falls below 30% (Stage 4) and especially below 15% (Stage 5), serious complications accelerate. Symptoms become pronounced: swelling in legs and ankles (edema), nausea, vomiting, loss of appetite, confusion, shortness of breath, and high blood pressure. Dangerous levels of potassium and phosphorus accumulate in the blood. Without dialysis or kidney transplantation, Stage 5 CKD is fatal.
What Research Shows About CKD Progression and Outcomes
Epidemiological data underscores the global burden of CKD. An estimated 753 million people worldwide had CKD in 2016. By 2015, CKD caused 1.2 million deaths annually—an increase from 409,000 deaths in 1990. The leading causes of CKD-related mortality are high blood pressure (550,000 deaths), diabetes (418,000 deaths), and glomerulonephritis (238,000 deaths).
Research consistently demonstrates that:
- Early intervention slows progression: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) reduce both blood pressure and proteinuria, slowing kidney disease progression and reducing cardiovascular complications—these are first-line agents for most CKD patients.
- Blood pressure control is critical: Tight control of hypertension in CKD significantly reduces progression to later stages and the risk of heart attack and stroke.
- Cardiovascular risk is markedly increased: People with CKD have substantially higher rates of atherosclerosis, heart disease, and death compared to the general population, even in early stages.
- Dietary modification helps: Plant-based diets with higher consumption of vegetables and lower intake of ultra-processed foods are associated with improved kidney function markers and reduced CKD progression.
Diagnosis Across Chronic Kidney Disease Stages
CKD is diagnosed using two primary tests:
- Blood test measuring creatinine: Used to calculate eGFR, which determines the stage
- Urine test for albumin: Detects protein leakage, indicating kidney damage
Additional tests may include ultrasound or kidney biopsy to identify the underlying cause. People with risk factors (diabetes, high blood pressure, family history, older age) should be screened regularly with these tests.
Who Should Be Evaluated and When Treatment Adjusts by Stage
Early Screening (Stages 1–2)
Screening is recommended for anyone with:
- Diabetes mellitus
- Hypertension (high blood pressure)
- Family history of CKD
- Age over 60
- Obesity or metabolic syndrome
- History of cardiovascular disease
Treatment Intensity Increases Across Stages
Stages 1–2: Blood pressure control (target usually <120/80 mmHg), blood sugar management, cholesterol control, ACEIs or ARBs, lifestyle modification.
Stages 3a–3b: Intensified medication management, monitoring for anemia and bone disease, potential specialist referral (nephrology), dietary restrictions begin (potassium, phosphorus, sodium limitations may be needed).
Stages 4–5: Preparation for renal replacement therapy (dialysis or transplant), medication adjustments for kidney function, careful management of electrolytes and fluid, subspecialty care essential.
Lifestyle Measures and Dietary Recommendations by CKD Stage
For all CKD stages, healthcare providers recommend:
- Healthy diet: Plant-based foods predominating, limited processed foods, moderate protein intake (higher in early stages, restricted in later stages)
- Regular physical activity: As tolerated; improves cardiovascular health and slows progression
- Blood pressure control: Target <120/80 mmHg for most; medication adherence critical
- Avoidance of NSAIDs: Over-the-counter pain relievers like ibuprofen and naproxen can harm remaining kidney function
- Blood sugar management: If diabetic; tight control reduces kidney disease progression
- Dietitian referral: For Stages 3–5 and anyone with specific nutritional concerns; personalized guidance on sodium, potassium, phosphorus, and fluid intake
Safety Considerations and Complications Across CKD Stages
As kidney function declines, several serious complications can develop:
- Hyperkalemia (elevated potassium): Usually emerges when eGFR < 20–25. Excess potassium can cause dangerous heart rhythms. Requires dietary restriction and sometimes medication.
- Hyperphosphatemia (elevated phosphorus): Contributes to vascular calcification and increased cardiovascular death. Managed through diet and medications.
- Anemia: From reduced erythropoietin production; causes fatigue, shortness of breath; treated with medications.
- Bone disease (CKD-MBD): Imbalances in calcium, phosphorus, and vitamin D lead to weak bones and vascular calcification.
- Hypertension: Worsens as kidney function declines; increases cardiovascular and stroke risk.
- Uremia: Accumulation of waste products causes nausea, confusion, pericarditis, and encephalopathy in advanced stages.
Drug interactions: Many common medications require dose adjustment or avoidance in CKD. Always inform healthcare providers of kidney disease status. NSAIDs, certain antibiotics, and other drugs are contraindicated or risky.
Key Takeaway: Chronic Kidney Disease Stages
Chronic kidney disease stages provide a standardized framework for understanding kidney function and guiding treatment. Stages 1–2 are often silent but detectable, making early screening essential for at-risk populations. Aggressive management of blood pressure and blood sugar in early stages can significantly slow or prevent progression.
As disease advances to Stages 4–5, complications become severe and life-threatening, requiring intensive specialist care and preparation for dialysis or transplantation. The five-stage system empowers patients and providers to intervene early, with evidence-based therapies like ACEIs/ARBs and lifestyle modification studied for its potential to extend quality of life and delay kidney failure. Anyone with risk factors should request eGFR and urine albumin testing; early detection is a game-changer.
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.